LataMed AI Corp. (OTC: LMED) announced today that it has initiated a strategic evaluation process with Vertice Seguros, a Venezuelan insurance provider, to explore integrating insurance products with the Company's digital healthcare ecosystem. The evaluation aims to determine the feasibility of offering life and health insurance through LataMed AI's platforms while providing Vertice Seguros clients access to telehealth, care coordination, analytics, and AI-enabled healthcare solutions.
Management believes this collaboration could create complementary commercial opportunities by expanding customer reach and increasing healthcare accessibility. Preliminary activities are underway to assess user onboarding, platform integration, operational workflows, regulatory considerations, and service deployment models. These steps will determine the scalability of a broader strategic relationship.
Dr. Kevin Rodan Levy, CEO of LataMed AI, stated: "Our vision is to create a more connected healthcare ecosystem where technology, care delivery, and financial protection solutions work together to improve accessibility and outcomes. We believe this evaluation process with Vertice Seguros represents an opportunity to explore how healthcare technology services and insurance solutions can be combined within a unified digital platform."
The Company believes that healthcare accessibility extends beyond care delivery to include financial protection solutions. Combining technology services with insurance may support greater patient engagement and improve long-term healthcare outcomes in underserved markets. This aligns with LataMed AI's strategy to build an integrated ecosystem combining AI, telehealth, analytics, pharmacy connectivity, and emergency response capabilities.
Any definitive arrangement would require successful completion of the evaluation, negotiation of final terms, regulatory approvals, and execution of definitive agreements. LataMed AI intends to provide updates as material developments occur. For more information, visit the Company's website at https://latamed.ai and review SEC filings at https://www.sec.gov.
